{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:47:27Z","timestamp":1789148847438,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1124\/jpet.106.109702","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T00:52:39Z","timestamp":1160009559000},"page":"458-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Nicotinamide Reverses Neurological and Neurovascular Deficits in Streptozotocin Diabetic Rats"],"prefix":"10.1016","volume":"320","author":[{"given":"M.J.","family":"Stevens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.R.","family":"Drel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.I.","family":"Abatan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.G.","family":"Obrosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.106.109702_bib1","doi-asserted-by":"crossref","unstructured":"Agthong S and Tomlinson DR (2002) Inhibition of p38 MAP kinase corrects biochemical and neurological deficits in experimental diabetic neuropathy. Ann NY Acad Sci 973: 359\u2013362.","DOI":"10.1111\/j.1749-6632.2002.tb04665.x"},{"key":"10.1124\/jpet.106.109702_bib2","doi-asserted-by":"crossref","unstructured":"Calcutt NA (2002) Potential mechanisms of neuropathic pain in diabetes. Int Rev Neurobiol 50: 205\u2013228.","DOI":"10.1016\/S0074-7742(02)50078-7"},{"key":"10.1124\/jpet.106.109702_bib3","doi-asserted-by":"crossref","unstructured":"Calcutt NA, Allendoerfer KL, Mizisin AP, Middlemas A, Freshwater JD, Burgers M, Ranciato R, Delcroix JD, Taylor FR, Shopiro R, et al. (2003) Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy. J Clin Investig 111: 507\u2013514.","DOI":"10.1172\/JCI15792"},{"key":"10.1124\/jpet.106.109702_bib4","doi-asserted-by":"crossref","unstructured":"Calcutt NA, Freshwater JD, and Mizisin AP (2004) Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 47: 718\u2013724.","DOI":"10.1007\/s00125-004-1354-2"},{"key":"10.1124\/jpet.106.109702_bib5","doi-asserted-by":"crossref","unstructured":"Cameron NE, Tuck Z, McCabe L, and Cotter MA (2001) Effect of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes. Diabetologia 44: 1161\u20131169.","DOI":"10.1007\/s001250100626"},{"key":"10.1124\/jpet.106.109702_bib6","doi-asserted-by":"crossref","unstructured":"Chong ZZ, Lin SH, and Maiese K (2002) Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endothelial cell injury. J Vasc Res 39: 131\u2013147.","DOI":"10.1159\/000057762"},{"key":"10.1124\/jpet.106.109702_bib7","doi-asserted-by":"crossref","unstructured":"Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, and Yorek MA (2001) Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 50: 1927\u20131937.","DOI":"10.2337\/diabetes.50.8.1927"},{"key":"10.1124\/jpet.106.109702_bib8","doi-asserted-by":"crossref","unstructured":"Dyck PJ, Dyck PJ, Larson TS, O\u2019Brien PC, and Velosa JA (2000) Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care 23: 510\u2013517.","DOI":"10.2337\/diacare.23.4.510"},{"key":"10.1124\/jpet.106.109702_bib9","doi-asserted-by":"crossref","unstructured":"Gale EA, Bingley PJ, Emmett CL, Collier T, and the European Nicotinamide Diabetes Intervention Trial (ENDIT) Group (2004) European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 363: 925\u2013931.","DOI":"10.1016\/S0140-6736(04)15786-3"},{"key":"10.1124\/jpet.106.109702_bib10","doi-asserted-by":"crossref","unstructured":"Garcia Soriano F, Virag L, Jagtap P, Szabo E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KG, Salzman AL, et al. (2001) Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 7: 108\u2013113.","DOI":"10.1038\/83241"},{"key":"10.1124\/jpet.106.109702_bib11","doi-asserted-by":"crossref","unstructured":"Gonzalez-Clemente JM, Mauricio D, Richart C, Broch, M, Caixas A, Megia A, Gimenez-Palop O, Simon I, Martinez-Riquelme A, Gimenez-Perez G, et al (2005) Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with wild type 1 diabetes mellitus. Clin Endocrinol 6: 525\u2013529.","DOI":"10.1111\/j.1365-2265.2005.02376.x"},{"key":"10.1124\/jpet.106.109702_bib12","doi-asserted-by":"crossref","unstructured":"Ha HC, Hester LD, and Snyder SH (2002) Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci USA 99: 3270\u20133275.","DOI":"10.1073\/pnas.052712399"},{"key":"10.1124\/jpet.106.109702_bib13","doi-asserted-by":"crossref","unstructured":"Hounsom L, Corder R, Patel J, and Tomlinson DR (2001) Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy. Diabetologia 44: 424\u2013428.","DOI":"10.1007\/s001250051638"},{"key":"10.1124\/jpet.106.109702_bib14","doi-asserted-by":"crossref","unstructured":"Ilnytska O, Lyzogubov VV, Stevens MJ, Drel VR, Mashtalir N, Pacher P, Yorek MA, and Obrosova IG (2006) PARP inhibition alleviated experimental diabetic sensory neuropathy. Diabetes 55: 1686\u20131694.","DOI":"10.2337\/db06-0067"},{"key":"10.1124\/jpet.106.109702_bib15","doi-asserted-by":"crossref","unstructured":"Johann V, Jeliaznik N, Schrage K, and Mey J (2003) Retinoic acid downregulates the expression of ciliary neurotrophic factor in rat Schwann cells. Neurosci Lett 339: 13\u201316.","DOI":"10.1016\/S0304-3940(02)01427-1"},{"key":"10.1124\/jpet.106.109702_bib16","doi-asserted-by":"crossref","unstructured":"Li F, Drel VR, Szabo C, Stevens MJ, and Obrosova IG (2005b) Low-dose poly(ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral neuropathy. Diabetes 54: 1514\u20131522.","DOI":"10.2337\/diabetes.54.5.1514"},{"key":"10.1124\/jpet.106.109702_bib17","doi-asserted-by":"crossref","unstructured":"Li F, Obrosova IG, Abatan O, Tian D, Larkin D, Stuenkel EL, and Stevens MJ (2005a) Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of streptozotocin-diabetic rats. Am J Physiol 288: E29\u2013E36.","DOI":"10.1152\/ajpendo.00168.2004"},{"key":"10.1124\/jpet.106.109702_bib18","doi-asserted-by":"crossref","unstructured":"Li F, Szabo C, Pacher P, Southan GJ, Abatan OI, Charniauskaya T, Stevens MJ, and Obrosova IG (2004) Evaluation of orally active poly(ADP-Ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy. Diabetologia 47: 710\u2013717.","DOI":"10.1007\/s00125-004-1356-0"},{"key":"10.1124\/jpet.106.109702_bib19","doi-asserted-by":"crossref","unstructured":"Maiese K and Chong ZZ (2003) Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharm Sci 24: 228\u2013232.","DOI":"10.1016\/S0165-6147(03)00078-6"},{"key":"10.1124\/jpet.106.109702_bib20","doi-asserted-by":"crossref","unstructured":"Matsuoka I, Meyer M, and Thoenen H (1991) Cell-type-specific regulation of nerve growth factor (NGF) synthesis in non-neuronal cells: comparison of Schwann cells with other cell types. J Neurosci 11: 3165\u20133177.","DOI":"10.1523\/JNEUROSCI.11-10-03165.1991"},{"key":"10.1124\/jpet.106.109702_bib21","doi-asserted-by":"crossref","unstructured":"Melo SS, Arantes MR, Meirelles MS, Jordao AA Jr, and Vannucchi H (2000) Lipid peroxidation in nicotinamide-deficient and nicotinamide-supplemented rats with streptozotocin-induced diabetes. Acta Diabetol 37: 33\u201339.","DOI":"10.1007\/s005920070033"},{"key":"10.1124\/jpet.106.109702_bib22","doi-asserted-by":"crossref","unstructured":"Minea C, Kuruvilla R, Merrikh H, and Eichberg J (2002) Altered arachidonic acid biosynthesis and antioxidant protection mechanisms in Schwann cells grown in elevated glucose. J Neurochem 81: 1253\u20131262.","DOI":"10.1046\/j.1471-4159.2002.00912.x"},{"key":"10.1124\/jpet.106.109702_bib23","doi-asserted-by":"crossref","unstructured":"Mirsky R, Parmantier E, McMahon AP, and Jessen KR (1999) Schwann cell-derived desert hedgehog signals nerve sheath formation. Ann NY Acad Sci 883: 196\u2013202.","DOI":"10.1111\/j.1749-6632.1999.tb08582.x"},{"key":"10.1124\/jpet.106.109702_bib24","doi-asserted-by":"crossref","unstructured":"Nakamura J, Kato K, Hamada Y, Nakayama M, Chaya S, Nakashima E, Narusa K, Kasuya Y, Mizubayashi R, Miwa K, et al. (1999) A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. Diabetes 48: 2090\u20132095.","DOI":"10.2337\/diabetes.48.10.2090"},{"key":"10.1124\/jpet.106.109702_bib25","doi-asserted-by":"crossref","unstructured":"Obrosova IG, Drel VR, Pacher P, Iinytska O, Wang Z, Stevens MJ, and Yorek MA (2005a) Oxidative-nitrosative stress and PARP activation in experimental diabetic neuropathy: the relation is revisited. Diabetes 54: 3435\u20133441.","DOI":"10.2337\/diabetes.54.12.3435"},{"key":"10.1124\/jpet.106.109702_bib26","doi-asserted-by":"crossref","unstructured":"Obrosova IG, Li F, Abatan OI, Forsell MA, Komjati K, Pacher P, Szabo C, and Stevens MJ (2004) Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes 53: 711\u2013720.","DOI":"10.2337\/diabetes.53.3.711"},{"key":"10.1124\/jpet.106.109702_bib27","doi-asserted-by":"crossref","unstructured":"Obrosova IG, Pacher P, Szabo C, Zsengeller Z, Hirooka H, Stevens MJ, and Yorek MA (2005b) Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications. Diabetes 54: 234\u2013242.","DOI":"10.2337\/diabetes.54.1.234"},{"key":"10.1124\/jpet.106.109702_bib28","unstructured":"Obrosova I, Yefimov A, Tsiruk V, Velikii N, Larin F, Moiseenok A, Pavlenya A, Zymatkina T, Zubkova S, Zuyeva N, et al. (1987) Biochemical mechanisms of hypoglycemic and hypolipidaemic effects of nicotinamide in various types of diabetes. Diabetol Croat 16: 21\u201335."},{"key":"10.1124\/jpet.106.109702_bib29","doi-asserted-by":"crossref","unstructured":"Price SA, Agthong S, Middlemas AB, and Tomlinson DR (2004) Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase. Diabetes 53: 1851\u20131856.","DOI":"10.2337\/diabetes.53.7.1851"},{"key":"10.1124\/jpet.106.109702_bib30","doi-asserted-by":"crossref","unstructured":"Purves T, Middlemas A, Agthong S, Jude EB, Boulton A, Fernyhough P, and Tomlinson DR (2001) A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J 15: 2508\u20132514.","DOI":"10.1096\/fj.01-0253hyp"},{"key":"10.1124\/jpet.106.109702_bib31","doi-asserted-by":"crossref","unstructured":"Schmeichel AM, Schmelzer JD, and Low PA (2003) Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 52: 165\u2013171.","DOI":"10.2337\/diabetes.52.1.165"},{"key":"10.1124\/jpet.106.109702_bib32","doi-asserted-by":"crossref","unstructured":"Shen C-C, Huang H-M, Ou H-C, Chen H-L, Chen W-C, and Jeng K-C (2004) Protective effect of nicotinamide on neuronal cells under oxygen and glucose deprivation and hypoxia\/reoxygenation Biomed Sci 11: 472\u2013481.","DOI":"10.1159\/000077897"},{"key":"10.1124\/jpet.106.109702_bib33","doi-asserted-by":"crossref","unstructured":"Sima AAF, Zhang W, Xu G, Sugimoto K, Guberski D, and Yorek MA (2000) A comparison of diabetic polyneuropathy in type II diabetic BBZDR\/Wor rats and in type I diabetic BB\/Wor rats. Diabetologia 43: 786\u2013793.","DOI":"10.1007\/s001250051376"},{"key":"10.1124\/jpet.106.109702_bib34","doi-asserted-by":"crossref","unstructured":"Southan GJ and Szabo C (2003) Poly(ADP-ribose) polymerase inhibitors. Curr Med Chem 10: 321\u2013340.","DOI":"10.2174\/0929867033368376"},{"key":"10.1124\/jpet.106.109702_bib35","doi-asserted-by":"crossref","unstructured":"Stevens MJ, Obrosova I, Cao X, Van Huysen C, and Greene DA (2000) Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49: 1006\u20131015.","DOI":"10.2337\/diabetes.49.6.1006"},{"key":"10.1124\/jpet.106.109702_bib36","doi-asserted-by":"crossref","unstructured":"Stevens MJ, Zhang W, Li F, and Sima AAF (2004) C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB\/Wor rats. Am J Physiol 287: E497\u2013E505.","DOI":"10.1152\/ajpendo.00048.2004"},{"key":"10.1124\/jpet.106.109702_bib37","doi-asserted-by":"crossref","unstructured":"Veres B, Radnai B, Gallyas F Jr, Varbiro G, Berente Z, Osz E, and Sumegi B (2004) Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice. J Pharmacol Exp Ther 310: 247\u2013255.","DOI":"10.1124\/jpet.104.065151"},{"key":"10.1124\/jpet.106.109702_bib38","doi-asserted-by":"crossref","unstructured":"Vincent AM, Stevens MJ, Backus C, McLean LL, and Feldman EL (2005) Cell culture modeling to test therapies against hyperglycemia-mediated oxidative stress and injury. Ant Red Sig 11\u201312: 1494\u20131506.","DOI":"10.1089\/ars.2005.7.1494"},{"key":"10.1124\/jpet.106.109702_bib39","doi-asserted-by":"crossref","unstructured":"Virag L and Szabo C (2002) The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54: 375\u2013429.","DOI":"10.1124\/pr.54.3.375"},{"key":"10.1124\/jpet.106.109702_bib40","doi-asserted-by":"crossref","unstructured":"Wang X, Martindale JL, Liu Y, and Holbrook NJ (1998) The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J 333: 291\u2013300.","DOI":"10.1042\/bj3330291"},{"key":"10.1124\/jpet.106.109702_bib41","doi-asserted-by":"crossref","unstructured":"Yang J, Klaidman LK, Nalbandian A, Oliver J, Chang ML, Chan PH, and Adams JD Jr (2002) The effects of nicotinamide on energy metabolism following transient focal cerebral ischemia in Wistar rats. Neurosci Lett 333: 91\u201394.","DOI":"10.1016\/S0304-3940(02)01005-4"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524331490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524331490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.106.109702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:08:23Z","timestamp":1740002903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524331490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0022356524331490"],"URL":"https:\/\/doi.org\/10.1124\/jpet.106.109702","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotinamide Reverses Neurological and Neurovascular Deficits in Streptozotocin Diabetic Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.106.109702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}